Innovating to improve health worldwide

Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda

On 9 April 2024, IFPMA, Interfarma, and FIFARMA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda. The letter is available for download in English, Portuguese, and Spanish.

Biopharmaceutical CEO Roundtable gathers in Athens, focusing on global health challenges and role of pharmaceutical innovation

The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in April, Greece, on 3 and 4 April 2024, to discuss global health challenges and public health policies impacting biomedical innovation. 05 April 2024, Athens – The CEOs of leading biopharmaceutical companies met in Athens, Greece, to discuss collaborative solutions that can...

Enhanced collaboration between anti-doping agency and big pharma bolsters support for clean sport among athletes

On 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent.